Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for O00422

Entry ID Method Resolution Chain Position Source
2HDE NMR - A 6-149 PDB
AF-O00422-F1 Predicted AlphaFoldDB

82 variants for O00422

Variant ID(s) Position Change Description Diseaes Association Provenance
rs752464689
CA6907632
4 E>V No ClinGen
ExAC
gnomAD
CA387494914
rs1161977637
5 S>* No ClinGen
TOPMed
CA387494909
rs1379939952
5 S>T No ClinGen
gnomAD
CA387494922
rs777404407
6 R>C No ClinGen
ExAC
gnomAD
CA387494924
rs1265831715
6 R>H No ClinGen
gnomAD
rs777404407
CA6907634
6 R>S No ClinGen
ExAC
gnomAD
rs1418054147
CA387494974
10 E>G No ClinGen
gnomAD
CA387495011
rs1487229594
13 K>R No ClinGen
gnomAD
CA6907636
rs757198379
17 E>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA387495068
rs1156759952
18 K>E No ClinGen
gnomAD
CA6907637
rs550761091
18 K>N No ClinGen
ExAC
gnomAD
CA6907638
rs745325674
19 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA387495151
rs1490307670
22 R>L No ClinGen
TOPMed
rs1267218087
CA387495173
24 K>T No ClinGen
TOPMed
rs1455361158
CA387495563
25 T>P No ClinGen
gnomAD
CA387495648
rs1210721036
30 L>P No ClinGen
TOPMed
CA387495723
rs1347601736
35 T>I No ClinGen
gnomAD
rs771411837
CA6907704
36 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA387495771
rs1351411347
40 H>Y No ClinGen
gnomAD
rs1206989775
CA387495808
43 M>I No ClinGen
gnomAD
rs1595288059
CA387495800
43 M>L No ClinGen
Ensembl
CA387495823
rs1290210041
44 D>E No ClinGen
gnomAD
CA387495846
rs1490340812
46 F>L No ClinGen
gnomAD
CA6907706
rs757818539
47 S>C No ClinGen
ExAC
CA387495860
rs1271435407
48 R>Q No ClinGen
gnomAD
CA6907707
rs781593093
48 R>W No ClinGen
ExAC
gnomAD
CA387495879
rs1565985582
50 N>S No ClinGen
Ensembl
CA6907709
rs769823450
51 V>G No ClinGen
ExAC
TOPMed
gnomAD
rs775710122
CA6907710
52 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs1804868
CA246587474
52 P>T No ClinGen
Ensembl
CA387495900
rs1364856311
53 S>T No ClinGen
gnomAD
rs1304907056
CA387495915
54 S>T No ClinGen
gnomAD
TCGA novel 55 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1306492238
CA387495948
57 Q>E No ClinGen
gnomAD
rs1336638264
CA387495956
58 I>V No ClinGen
gnomAD
rs1185009308
CA387496077
62 M>V No ClinGen
TOPMed
CA246592292
rs954845353
73 V>A No ClinGen
TOPMed
TCGA novel 73 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 74 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs968775589
CA246592300
75 E>D No ClinGen
Ensembl
CA246592299
rs1021730701
75 E>V No ClinGen
Ensembl
CA6907730
rs749330807
76 V>I No ClinGen
ExAC
gnomAD
CA387496237
rs1396811280
84 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs748376383
CA6907733
85 T>I No ClinGen
ExAC
gnomAD
rs1330254667
CA387496252
86 H>Y No ClinGen
TOPMed
gnomAD
CA387496265
rs1292926263
87 F>L No ClinGen
TOPMed
rs1481838912
CA387496276
88 N>H No ClinGen
gnomAD
CA6907734
rs770685260
88 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA6907735
rs776479725
89 F>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA6907736
rs759393970
91 I>V No ClinGen
ExAC
gnomAD
CA387496321
rs1184964859
92 V>I No ClinGen
gnomAD
CA387496346
rs1417292145
94 T>A No ClinGen
gnomAD
CA6907737
rs769673358
95 D>N No ClinGen
ExAC
gnomAD
CA387496401
rs1468041449
99 P>H No ClinGen
gnomAD
CA6907738
rs775015278
100 G>V No ClinGen
ExAC
gnomAD
CA387496419
rs1405698390
101 Y>C No ClinGen
gnomAD
CA6907739
rs762493934
102 R>* No ClinGen
ExAC
gnomAD
rs763576966
CA6907740
102 R>Q No ClinGen
ExAC
TOPMed
rs1029458992
CA246592710
106 I>M No ClinGen
gnomAD
rs1403487127
CA387496514
106 I>V No ClinGen
gnomAD
rs1224924349
CA387496539
108 S>I No ClinGen
gnomAD
rs768222752
CA6907760
112 G>V No ClinGen
ExAC
gnomAD
rs1315750637
CA387496622
116 T>A No ClinGen
TOPMed
gnomAD
CA387496713
rs1465282232
124 S>L No ClinGen
Ensembl
CA387496734
rs1408637048
126 K>R No ClinGen
TOPMed
TCGA novel 128 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1481314861
CA387496824
135 I>V No ClinGen
gnomAD
CA387496840
rs1565987160
137 I>M No ClinGen
Ensembl
CA246592776
rs762471125
137 I>V No ClinGen
Ensembl
CA246592777
rs373878914
139 P>A No ClinGen
ESP
CA6907767
rs748207834
139 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA6907768
rs755534247
141 N>H No ClinGen
ExAC
gnomAD
rs1395783276
CA387496869
143 A>T No ClinGen
Ensembl
rs1804867
CA246592799
144 P>L No ClinGen
gnomAD
CA6907771
rs201976008
145 P>L No ClinGen
1000Genomes
ExAC
gnomAD
rs752761827
CA6907770
145 P>S No ClinGen
ExAC
gnomAD
CA246592846
rs17852855
146 P>T No ClinGen
Ensembl
rs146801945
CA246592853
147 S>P No ClinGen
ESP
TOPMed
gnomAD
CA6907774
rs376710499
149 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA246592893
rs148923843
150 M>L No ClinGen
ESP
ExAC
gnomAD
rs148923843
CA6907775
150 M>V No ClinGen
ESP
ExAC
gnomAD
CA6907776
rs749228463
151 R>T No ClinGen
ExAC
gnomAD

No associated diseases with O00422

No regional properties for O00422

Type Name Position InterPro Accession
No domain, repeats, and functional sites for O00422

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Nucleus speckle
  • Shuttles between the nucleus and the cytoplasm (PubMed:16314458)
  • Colocalizes with ACIN1 and SRSF2 in nuclear speckles (PubMed:20966198)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
ASAP complex A protein complex involved in regulation of mRNA processing and apoptosis. It binds to RNA in a sequence-independent manner and is recruited to the EJC prior to or during the splicing process. In humans the core proteins are RNPS1, SAP18 and ACIN1.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
histone deacetylase complex A protein complex that possesses histone deacetylase activity.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.
transcription corepressor activity A transcription coregulator activity that represses or decreases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Corepressors often act by altering chromatin structure and modifications. For example, one class of transcription corepressors modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators.

7 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
negative regulation of DNA-templated transcription Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
negative regulation of mRNA splicing, via spliceosome Any process that stops, prevents or reduces the rate or extent of mRNA splicing via a spliceosomal mechanism.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
regulation of alternative mRNA splicing, via spliceosome Any process that modulates the frequency, rate or extent of alternative splicing of nuclear mRNAs.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3T022 SAP18 Histone deacetylase complex subunit SAP18 Bos taurus (Bovine) PR
O55128 Sap18 Histone deacetylase complex subunit SAP18 Mus musculus (Mouse) PR
10 20 30 40 50 60
MAVESRVTQE EIKKEPEKPI DREKTCPLLL RVFTTNNGRH HRMDEFSRGN VPSSELQIYT
70 80 90 100 110 120
WMDATLKELT SLVKEVYPEA RKKGTHFNFA IVFTDVKRPG YRVKEIGSTM SGRKGTDDSM
130 140 150
TLQSQKFQIG DYLDIAITPP NRAPPPSGRM RPY